Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

RDNT vs GRAL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

RDNT Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

RDNT Overall Winner 6-Pillar Tally: RDNT 5 – 1 GRAL Matrix Metrics: RDNT 7 – 3 GRAL

As of Nov 16, 2026, RadNet, Inc. (RDNT) is the stronger overall head-to-head candidate over GRAIL, Inc. (GRAL) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RDNT carries a Unified Composite Score of 43.8/100 (HOLD) at $76.89 (74.3x Forward P/E, 4.7% operating margin), whereas GRAL carries 54.5/100 (HOLD) at $105.60 (1.1x Forward P/E, -332.0% operating margin).

  • Composite vs. Pillar Nuance: While GRAL currently prints a higher short-term Unified Composite Score (54.5/100 HOLD vs. RDNT 43.8/100 HOLD), RDNT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (4.7% vs. -332.0% operating margin) and revenue trajectory (+22.1% vs. +3.7% YoY).
  • Technical & Structure Timing Caution: RDNT trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 57.2); meanwhile GRAL is in a Breakdown options structure phase (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RDNT vs GRAL
RDNT NASDAQ Head-to-Head Winner
RadNet, Inc. Common Stock
Services-Medical Laboratories
$76.89
+0.62% 1D
Market Cap $6.0B
TTM Revenue $2.38B
Forward P/E 74.3x
Beta / 30D Vol 0.72β · 44% Vol
Unified Composite Score
43.8 / 100 HOLD
Tech 38.0 Fund 50.0 Flow 66.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 57
RSI-14: 57.2 · SMA20: $74.36 · SMA50: $72.84
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
TTM Revenue $167M
Forward P/E 1.1x
Beta / 30D Vol 3.09β · 99% Vol
Unified Composite Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 37.7 · SMA20: $132.32 · SMA50: $121.37

6-Pillar Scorecard Institutional Category Breakdown (RDNT 5 – 1 GRAL)

Columns: Metric · RDNT · GRAL
1. Valuation Multiples GRAL
Forward P/E 74.3x 1.1x
Trailing P/E 36.6x 1.1x
PEG Ratio 0.96x N/M
EV / Revenue 3.1x 31.6x
2. Growth & Scale RDNT
Revenue Growth (YoY) +22.1% +3.7%
Earnings Growth (YoY) -28.6% +0.0%
TTM Revenue (USD) $2.38B $167M
Market Cap $6.0B $5.2B
3. Profitability & Quality RDNT
Gross Margin 17.0% 46.7%
Operating Margin 4.7% -332.0%
Net Profit Margin -0.9% -243.8%
Return on Equity (ROE) 1.8% -17.3%
4. Balance Sheet & Cash Flow RDNT
Cash Generation (TTM) $115M -$312M
Cash Flow Margin 4.8% N/A
Net Cash / Leverage $1.42B Net Debt (1.94x D/E) $57M Net Debt (0.03x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning RDNT
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 57.2% (7th %ile) 93.0% (53rd %ile)
Put/Call OI Skew 0.99x (Balanced) 0.81x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat RDNT
OpEx & R&D Intensity 12.3% of Rev ($293M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Diagnostics & Research Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RDNT (7) vs GRAL (3)
Institutional Metric RDNT GRAL Criterion Row Edge
Market Capitalization
Scale
$6.0B $5.2B Larger Scale RDNT
Trailing P/E Ratio
Valuation
36.6x 1.1x Lower Multiple GRAL
Forward P/E Ratio
Valuation
74.3x 1.1x Lower Multiple GRAL
Revenue Growth (YoY)
Growth
+22.1% +3.7% Higher Growth RDNT
Operating Margin (TTM)
Profitability
4.7% -332.0% Higher Margin RDNT
Net Profit Margin
Profitability
-0.9% -243.8% Higher Margin RDNT
Return on Equity (ROE)
Capital Efficiency
1.8% -17.3% Higher ROE RDNT
52-Week Range Position
Momentum
74% ($51–$86) 51% ($42–$166) Stronger Trend RDNT
Beta / 30D Volatility
Risk Regime
0.72β · 44% Vol 3.09β · 99% Vol Lower Realized Risk RDNT
Unified Institutional Score
Composite Signal
43.8 / 100 (HOLD) 54.5 / 100 (HOLD) Higher Composite GRAL
Trailing 12M Revenue (USD)
Operating Scale
$2.38B $167M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.0% 46.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.96x PEG · 3.1x EV/Rev N/M PEG · 31.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$115M ($1.42B Net Debt (1.94x D/E)) -$312M ($57M Net Debt (0.03x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RDNT +22.12 pp
RDNT: +11.76% · GRAL: -10.36%
3M Horizon GRAL +49.7 pp
RDNT: +1.26% · GRAL: +50.96%
6M Horizon GRAL +30.27 pp
RDNT: +46.76% · GRAL: +77.03%
1Y Horizon GRAL +22.25 pp
RDNT: +4.67% · GRAL: +26.92%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period RDNT Revenue GRAL Revenue RDNT Op. Margin GRAL Op. Margin Margin Leader
FY2018 $980M N/A 3.2% N/A RDNT
FY2019 $1.15B N/A 6.1% N/A RDNT
FY2020 $1.07B N/A 3.3% N/A RDNT
FY2021 $1.32B N/A 6.3% N/A RDNT
FY2022 $1.43B N/A 3.2% N/A RDNT
FY2023 $1.62B $90M 6.1% -1627.6% RDNT
FY2024 $1.83B $130M 5.7% -1743.0% RDNT
FY2025 $2.04B $150M 3.0% -382.0% RDNT

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RDNT CONSOLIDATION
69d in phase · OBV NEUTRAL
Current IV 57.2%
IV Percentile 7th %ile
Put/Call OI Skew 0.99x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RDNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GRAL BREAKDOWN
12d in phase · OBV DISTRIBUTION
Current IV 93.0%
IV Percentile 53rd %ile
Put/Call OI Skew 0.81x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact GRAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RDNT Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $6.0B market capitalization and 4.7% operating margin.
OpEx & R&D Reinvestment 12.3% of Rev ($293M)
90D Engineering Disclosures 0 Published
GRAL Moat Profile Cyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $5.2B market capitalization and -332.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ RDNT vs GRAL Key Questions & Quantitative Answers

As of Nov 16, 2026, RadNet, Inc. (RDNT) is the stronger overall head-to-head candidate over GRAIL, Inc. (GRAL) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). RDNT carries a Unified Composite Score of 43.8/100 (HOLD) at $76.89 (74.3x Forward P/E, 4.7% operating margin), whereas GRAL carries 54.5/100 (HOLD) at $105.60 (1.1x Forward P/E, -332.0% operating margin). Composite vs. Pillar Nuance: While GRAL currently prints a higher short-term Unified Composite Score (54.5/100 HOLD vs. RDNT 43.8/100 HOLD), RDNT captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (4.7% vs. -332.0% operating margin) and revenue trajectory (+22.1% vs. +3.7% YoY). Technical & Structure Timing Caution: RDNT trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 57.2); meanwhile GRAL is in a Breakdown options structure phase (RSI 37.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

RDNT leads the Growth & Scale pillar: RDNT posts +22.1% YoY revenue growth and -28.6% YoY earnings growth on $2.38B TTM revenue (17.0% gross margin, 4.7% operating margin), compared with GRAL at +3.7% YoY revenue growth and +0.0% YoY earnings growth on $167M TTM revenue (46.7% gross margin, -332.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), RDNT cumulative revenue shifted +108.2% while GRAL shifted +66.7%. In operating R&D and SG&A reinvestment, RDNT deploys 12.3% of Rev ($293M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GRAL.

GRAL screens cheaper on headline valuation multiples. RDNT trades at 74.3x Forward P/E, 36.6x Trailing P/E, 0.96x PEG, and 3.1x EV/Revenue (4.8% FCF margin), whereas GRAL trades at 1.1x Forward P/E, 1.1x Trailing P/E, N/M PEG, and 31.6x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RDNT (1.8% ROE) versus GRAL (-17.3% ROE) capital efficiency.

In options market volatility and institutional positioning, RDNT carries 57.2% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.99x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.72β · 44% Vol realized risk). By comparison, GRAL carries 93.0% implied volatility (53rd %ile, Balanced (25th–60th %ile)), a 0.81x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.09β · 99% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.